jRCTs051220110招募中不适用
Specified clinical trial for fecal microbiota transplantation and gut microbiota reconstruction in patients with refractory diarrhea
未提供0 个研究点目标入组 10 人开始时间: 2023年6月6日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 18age old over 至 No limit(—)
- 性别
- All
入选标准
- •Study subject:
- •(1) Aged 18 years or older at informed consent.
- •(2) Patient with prolonged diarrhea more than 10 days despite of standard treatment for diarrhea, or who continue to have diarrhea without using antidiarrheal drugs.
- •(3) Patient with dysbiosis in the gut assessed using stool smear.
- •(4) Patient with written consent to participate in this study from the patient or his/her surrogate.
- •(1) Aged 18-70 years (If possible, relatives of the study subject).
- •(2) Patient without dysbiosis in the gut assessed using stool smear.
- •(3) If the study subject has a food allergy, person who is possible not to consume the food for at least 5 days before stool collection.
- •(4) Person with written consent from the person regarding the implementation of interview and various tests specified in this study and the provision of stool.
排除标准
- •Study subject:
- •(1) Patient with shock (blood lactate level 18 mg/dL or higher) or who using catecholamines.
- •(2) Patient with severe immunodeficiency <500 / microL of neutrophils.
- •(3) Patient who cannot expect a prognosis of 3 months or more even if diarrhea have subsided.
- •(4) Patient who are judged by the investigator to be inappropriate as research subjects for other reasons.
- •(1) Person suspected to have infection by interviewing and screening for blood and stool tests, or who have disease that should be excluded.
- •Excluded diseases: inflammatory bowel disease, irritable bowel syndrome, chronic diarrhea, severe constipation, malignant tumor under treatment, autoimmune disease, severe obesity, Parkinson's disease, autism, depression, Creutzfeldt-Jakob's disease.
- •For cytomegalovirus and EB virus, when the study subject is not infected, if the donor's screening test result is positive, it is non-eligible.
- •(2) Parson who are judged by the investigator to be inappropriate as doner for other reasons
结局指标
主要结局
-
Adverse events
次要结局
- Changes in stool shape
- Changes in gut microbiota
研究者
相似试验
进行中(未招募)
不适用
HFVI StudyOsteoarthritisjRCTs06224001350
进行中(未招募)
不适用
FF01-01 StudyjRCT2012240059430
进行中(未招募)
不适用
FASTOP studyjRCTs04223007221
已完成
不适用
Trial on the effect of biventricUlar pacinG in patients with bradycardia prEserved LV functioN, with the aim of Decreasing Heart failure and ATrial fibrillation.Sick Sinus SyndromeAV block, Sick Sinus Syndrome - Bradycardia formCirculatory SystemISRCTN04561582Olomouc University Hospital (Czech Rebublic)120
进行中(未招募)
不适用
MANTIS studyjRCT104224000422
